CE: Multisystem Inflammatory Syndrome in Children: A Review.
Journal
The American journal of nursing
ISSN: 1538-7488
Titre abrégé: Am J Nurs
Pays: United States
ID NLM: 0372646
Informations de publication
Date de publication:
01 May 2021
01 May 2021
Historique:
entrez:
19
4
2021
pubmed:
20
4
2021
medline:
4
5
2021
Statut:
ppublish
Résumé
The coronavirus disease 2019 (COVID-19) pandemic has impacted the health of children worldwide. Although overall mortality from COVID-19 in children remains low, an associated multisystem inflammatory disorder has emerged. The disorder has been recognized and named multisystem inflammatory syndrome in children (MIS-C) by the World Health Organization and the Centers for Disease Control and Prevention. This comprehensive review describes the epidemiology, pathophysiology, signs and symptoms, other potential diagnoses, and treatments relevant to MIS-C. The review also includes patient and family education and anticipatory guidance, and discusses nursing implications for nurses working in various roles and settings, including direct care, research, and public health.
Identifiants
pubmed: 33872261
doi: 10.1097/01.NAJ.0000749756.12090.63
pii: 00000446-202105000-00023
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
26-37Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
World Health Organization. Timeline: WHO's COVID-19 response . 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline .
Centers for Disease Control and Prevention. Information for healthcare providers about multisystem inflammatory syndrome in children (MIS-C) . 2020. https://www.cdc.gov/mis-c/hcp .
World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 . Geneva, Switzerland; 2020 May 15. WHO/2019-nCoV/Sci_Brief/Multisystem_Syndrome_Children/2020.1. Scientific brief; https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 .
Centers for Disease Control and Prevention. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States . Atlanta; 2021 Jan 8. https://www.cdc.gov/mis-c/cases/index.html .
DeBiasi RL, et al. Severe coronavirus disease-2019 in children and young adults in the Washington, DC, metropolitan region. J Pediatr 2020;223:199–203.e1.
Hong H, et al. Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatr Neonatol 2020;61(2):131–2.
Liguoro I, et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr 2020;179(7):1029–46.
Lu X, et al. SARS-CoV-2 infection in children. N Engl J Med 2020;382(17):1663–5.
Shekerdemian LS, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 2020;174(9):868–73.
Zachariah P, et al. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children's hospital in New York City, New York. JAMA Pediatr 2020;174(10):e202430.
Riphagen S, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020;395(10237):1607–8.
Toubiana J, et al. Kawasaki-like multisystem inflammatory syndrome in children during the Covid-19 pandemic in Paris, France: prospective observational study. BMJ 2020;369:m2094.
Waltuch T, et al. Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med 2020;38(10):2246.e3–e6.
Whittaker E, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA 2020;324(3):259–69.
Feldstein LR, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020;383(4):334–46.
Verdoni L, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet 2020;395(10239):1771–8.
Miller J, et al. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children that is related to coronavirus disease 2019: a single center experience of 44 cases. Gastroenterology 2020;159(4):1571–4.e2.
Bixler D, et al. SARS-CoV-2-associated deaths among persons aged <21 Years—United States, February 12-July 31, 2020. MMWR Morb Mortal Wkly Rep 2020;69(37):1324–9.
Chang TH, et al. Clinical characteristics and diagnostic challenges of pediatric COVID-19: a systematic review and meta-analysis. J Formos Med Assoc 2020;119(5):982–9.
Chen A, et al. Differences in clinical and imaging presentation of pediatric patients with COVID-19 in comparison with adults. Radiol Cardiothorac Imaging 2020;2(2).
Denina M, et al. Lung ultrasound in children with COVID-19. Pediatrics 2020;146(1).
Dong Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020;145(6).
Li Y, et al. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-gamma as biomarkers for early recognition. Pediatr Rheumatol Online J 2019;17(1):1.
Steinberger S, et al. CT features of coronavirus disease (COVID-19) in 30 pediatric patients. AJR Am J Roentgenol 2020;215(6):1303–11.
Xu X, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A 2020;117(20):10970–5.
Chiotos K, et al. Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series. J Pediatric Infect Dis Soc 2020;9(3):393–8.
McCrindle BW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 2017;135(17):e927–e999.
Royal College of Paediatrics and Child Health. Paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS)—guidance for clinicians . London; 2020 May. https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf .
Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) . Atlanta; 2020 May 14. Emergency preparedness and response; health alert network; https://emergency.cdc.gov/han/2020/han00432.asp .
McKinley J. New York City region is now an epicenter of the coronavirus pandemic. New York Times 2020 Mar 22. https://www.nytimes.com/2020/03/22/nyregion/Coronavirus-new-York-epicenter.html .
Belhadjer Z, et al. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation 2020;142(5):429–36.
Ravelli A, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation collaborative initiative. Ann Rheum Dis 2016;75(3):481–9.
Shimabukuro-Vornhagen A, et al. Cytokine release syndrome. J Immunother Cancer 2018;6(1):56.
Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science 2020;368(6490):473–4.
Li Y, et al. Immune-related factors associated with pneumonia in 127 children with coronavirus disease 2019 in Wuhan. Pediatr Pulmonol 2020;55(9):2354–60.
Esper F, et al. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis 2005;191(4):499–502.
Chiotos K, et al. Emergency department, ICU and inpatient clinical pathway for evaluation of possible multisystem inflammatory syndrome (MIS-C) . Children's Hospital of Philadelphia. 2020. https://www.chop.edu/clinical-pathway/multisystem-inflammatory-syndrome-mis-c-clinical-pathway .
Hennon TR, et al. COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines; a Western New York approach. Prog Pediatr Cardiol 2020:101232.
Hameed S, et al. Spectrum of imaging findings at chest radiography, US, CT, and MRI in multisystem inflammatory syndrome in children associated with COVID-19. Radiology 2021;298(1):E1–E10.
Gómez-Mesa JE, et al. Thrombosis and coagulopathy in COVID-19. Curr Probl Cardiol 2020:100742.
American College of Rheumatology. Clinical guidance for pediatric patients with multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 and hyperinflammation in COVID-19 . Atlanta; 2020 Jul 23. https://www.rheumatology.org/Portals/0/Files/ACR-COVID-19-Clinical-Guidance-Summary-MIS-C-Hyperinflammation.pdf .
CLN Stat. SARS-CoV-2 cycle threshold: a metric that matters (or not). Clinical Laboratory News / American Association for Clinical Chemistry . 2020. https://www.aacc.org/cln/cln-stat/2020/december/3/sars-cov-2-cycle-threshold-a-metric-that-matters-or-not .
Wilkins AL, et al. Toxic shock syndrome—the seven Rs of management and treatment. J Infect 2017;74 Suppl 1:S147–S152.
Ouldali N, et al. Association of intravenous immunoglobulins plus methylprednisolone vs immunoglobulins alone with course of fever in multisystem inflammatory syndrome in children. JAMA 2021;325(9):855–64.
American Academy of Pediatrics. Multisystem inflammatory syndrome in children (MIS-C) interim guidance . Itasca, IL; 2020. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance .
Watson RS, et al. Life after critical illness in children: toward an understanding of pediatric post-intensive care syndrome. J Pediatr 2018;198:16–24.
Centers for Disease Control and Prevention. Interim infection prevention and control recommendations for healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic (updated Dec 14) . 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html .
Centers for Disease Control and Prevention. Considerations for alternate care sites: infection prevention and control considerations for alternate care sites (updated Apr 24) . 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/alternative-care-sites.html .
National Institutes of Health, COVID-19 Treatment Guidelines Panel COVID-19 treatment guidelines: what's new in the guidelines (last updated Jan 14) . 2021. https://www.covid19treatmentguidelines.nih.gov/whats-new .
American Academy of Pediatrics. COVID-19 planning considerations: guidance for school re-entry; American Academy of Pediatrics interim clinical guidance . Itasca, IL; 2020 Aug 18. https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-planning-considerations-return-to-in-person-education-in-schools .
Chu DK, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 2020;395(10242):1973–87.
Davies NG, et al. Age-dependent effects in the transmission and control of COVID-19 epidemics. Nat Med 2020;26(8):1205–11.
Rubin D, et al. Policy review: evidence and considerations for school reopenings . Philadelphia: Children's Hospital of Philadelphia Policy Lab; 2020 Aug 19. https://policylab.chop.edu/sites/default/files/pdf/publications/PolicyLab-Policy-Review-Evidence-Considerations-School-Reopenings-2020.pdf .